Literature DB >> 28775201

Off-Target 18F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation.

Jae Yong Choi1,2, Hanna Cho3, Sung Jun Ahn4, Jae Hoon Lee1, Young Hoon Ryu5, Myung Sik Lee3, Chul Hyoung Lyoo6.   

Abstract

Off-target binding in the basal ganglia is commonly observed in the 18F-AV-1451 PET studies of the elderly. We sought to investigate the relationship between this phenomenon in the basal ganglia and iron accumulation using iron-sensitive R2* MRI.
Methods: Fifty-nine healthy controls and 61 patients with Alzheimer disease and mild cognitive impairment underwent 18F-AV-1451 PET and R2* MRI studies. A correlation analysis was performed for age, 18F-AV-1451 binding, and R2* values.
Results: There was an age-related increase in both 18F-AV-1451 binding in the basal ganglia and R2* values in the putamen in both the controls and the Alzheimer disease/mild cognitive impairment patients. 18F-AV-1451 binding in the basal ganglia increased with R2* values.
Conclusion: Off-target 18F-AV-1451 binding in the basal ganglia is associated with the age-related increases in iron accumulation. Postmortem studies are required to further investigate the nature of this association.
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  18F-AV-1451; PET; aging; basal ganglia; iron

Mesh:

Substances:

Year:  2017        PMID: 28775201     DOI: 10.2967/jnumed.117.195248

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  36 in total

1.  Biomarker Localization, Analysis, Visualization, Extraction, and Registration (BLAzER) Methodology for Research and Clinical Brain PET Applications.

Authors:  Fabio Raman; Sameera Grandhi; Charles F Murchison; Richard E Kennedy; Susan Landau; Erik D Roberson; Jonathan McConathy
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  Regional times to equilibria and their impact on semi-quantification of [18F]AV-1451 uptake.

Authors:  Kerstin Heurling; Ruben Smith; Olof T Strandberg; Martin Schain; Tomas Ohlsson; Oskar Hansson; Michael Schöll
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-03       Impact factor: 6.200

3.  [18F]-AV-1451 tau PET imaging in Alzheimer's disease and suspected non-AD tauopathies using a late acquisition time window.

Authors:  Julien Lagarde; Pauline Olivieri; Fabien Caillé; Philippe Gervais; Jean-Claude Baron; Michel Bottlaender; Marie Sarazin
Journal:  J Neurol       Date:  2019-09-18       Impact factor: 4.849

4.  [18F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation.

Authors:  F Ali; J L Whitwell; P R Martin; M L Senjem; D S Knopman; C R Jack; V J Lowe; R C Petersen; B F Boeve; K A Josephs
Journal:  J Neurol       Date:  2018-03-01       Impact factor: 4.849

5.  [18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease.

Authors:  Jennifer L Whitwell; Jonathan Graff-Radford; Nirubol Tosakulwong; Stephen D Weigand; Mary Machulda; Matthew L Senjem; Christopher G Schwarz; Anthony J Spychalla; David T Jones; Daniel A Drubach; David S Knopman; Bradley F Boeve; Nilüfer Ertekin-Taner; Ronald C Petersen; Val J Lowe; Clifford R Jack; Keith A Josephs
Journal:  Ann Neurol       Date:  2018-02-06       Impact factor: 10.422

6.  Corticobasal degeneration: key emerging issues.

Authors:  F Ali; K A Josephs
Journal:  J Neurol       Date:  2017-10-23       Impact factor: 4.849

7.  Multimodal neuroimaging relationships in progressive supranuclear palsy.

Authors:  Irene Sintini; Christopher G Schwarz; Matthew L Senjem; Robert I Reid; Hugo Botha; Farwa Ali; J Eric Ahlskog; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  Parkinsonism Relat Disord       Date:  2019-07-02       Impact factor: 4.891

8.  Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span.

Authors:  Suzanne L Baker; Theresa M Harrison; Anne Maass; Renaud La Joie; William J Jagust
Journal:  J Nucl Med       Date:  2019-03-15       Impact factor: 10.057

9.  Multi-Modal Signatures of Tau Pathology, Neuronal Fiber Integrity, and Functional Connectivity in Traumatic Brain Injury.

Authors:  Dustin W Wooten; Laura Ortiz-Terán; Nevena Zubcevik; Xiaomeng Zhang; Chuan Huang; Jorge Sepulcre; Nazem Atassi; Keith A Johnson; Ross D Zafonte; Georges El Fakhri
Journal:  J Neurotrauma       Date:  2019-08-01       Impact factor: 5.269

Review 10.  Neuroimaging of Alzheimer's disease: focus on amyloid and tau PET.

Authors:  Hiroshi Matsuda; Yoko Shigemoto; Noriko Sato
Journal:  Jpn J Radiol       Date:  2019-09-06       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.